Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",27009,124,0.81 [0.57-1.16],0.2542631267818616
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",27773,209,0.94 [0.70-1.27],0.7003307775582845
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",27488,1361,0.81 [0.73-0.90],7.335404787018194e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Candidiasis,27798,481,0.83 [0.70-0.99],0.0416011539231686
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,26934,3562,0.90 [0.84-0.96],0.0017544355053286
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),27166,2935,0.86 [0.80-0.93],0.0001081522648092
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,27504,1396,0.86 [0.77-0.95],0.0041170694377231
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,27692,93,0.85 [0.56-1.30],0.4538644621119118
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,25905,836,0.81 [0.70-0.92],0.0014979584477483
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,25062,980,0.75 [0.66-0.84],2.2253621975557827e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,25075,267,0.77 [0.61-0.97],0.0250859530897151
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,19504,1710,0.79 [0.72-0.87],1.3156461192064783e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,24831,380,0.85 [0.69-1.04],0.1150577543139874
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,27737,1629,0.90 [0.81-0.99],0.0335934293757414
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Mycoses,27865,548,0.82 [0.70-0.97],0.0193738111806413
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,27094,967,0.74 [0.66-0.84],6.737840088423641e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,27808,923,0.82 [0.72-0.93],0.002779096551434
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,26317,209,0.94 [0.70-1.25],0.6523834100705237
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,27928,47,0.71 [0.42-1.19],0.1917319639909061
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Other septicaemia,27693,808,0.82 [0.72-0.94],0.0055747583131919
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,27683,84,1.20 [0.72-2.00],0.4774488339641927
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Other viral diseases,27831,199,1.16 [0.84-1.60],0.37930430853516
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",27812,180,1.23 [0.87-1.73],0.2458342372841373
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,26477,350,0.77 [0.63-0.95],0.013832617090034
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,26395,268,0.96 [0.74-1.25],0.7676971695802947
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,26241,133,0.96 [0.66-1.40],0.8402836038265762
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,27906,37,1.64 [0.72-3.71],0.2396960234735885
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,27850,164,0.71 [0.54-0.92],0.0101104551231501
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Viral warts,27735,49,0.88 [0.50-1.57],0.6661680199861834
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],27766,80,0.61 [0.44-0.85],0.0032457278960901
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign lipomatous neoplasm,27657,245,0.88 [0.68-1.14],0.3272538561392918
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,27824,72,0.70 [0.48-1.04],0.0792887663507023
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,27820,71,1.44 [0.81-2.56],0.2152247570143736
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",27631,1256,0.91 [0.81-1.02],0.089686421282576
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign neoplasm of meninges,27901,83,0.71 [0.49-1.03],0.0701089355417648
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,27859,66,0.85 [0.52-1.37],0.4986873833158265
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,27894,139,0.77 [0.56-1.05],0.1025521741807606
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign neoplasm of ovary,27843,180,0.94 [0.69-1.28],0.7035615312255292
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign neoplasm: Ascending colon,27906,288,0.91 [0.71-1.16],0.4559799540294094
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign neoplasm: Caecum,27912,257,0.91 [0.70-1.17],0.4682858240566407
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",27838,67,1.19 [0.67-2.09],0.5562708498063267
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign neoplasm: Descending colon,27909,158,0.89 [0.64-1.22],0.4651089787215721
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign neoplasm: Rectum,27869,289,0.75 [0.61-0.93],0.0082597983596557
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,27818,512,0.90 [0.75-1.07],0.2333832379295106
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign neoplasm: Transverse colon,27907,307,0.92 [0.73-1.17],0.5131214903412038
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Carcinoma in situ of breast,22619,141,1.06 [0.74-1.53],0.7450348773247562
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",22709,169,1.08 [0.77-1.51],0.6574004232559832
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",22689,32,1.19 [0.53-2.68],0.6799561418340645
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",22725,68,0.92 [0.56-1.50],0.7327523892204163
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",27859,140,0.86 [0.62-1.20],0.3834127370669611
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Haemangioma, any site",27860,138,0.88 [0.63-1.24],0.4690534122734582
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Leiomyoma of uterus,26922,598,1.13 [0.94-1.36],0.1881874056557103
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Lung cancer and mesothelioma,20039,317,0.80 [0.64-1.01],0.0564131410239721
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Lymphoid leukaemia,22694,37,0.79 [0.43-1.42],0.4262506011841184
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",22834,177,1.12 [0.80-1.57],0.5009891086136972
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",22774,117,0.99 [0.67-1.47],0.9542921960973312
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",22848,191,1.28 [0.91-1.80],0.1640102836220964
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",22729,72,0.78 [0.50-1.20],0.2589622568442629
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",22730,73,0.72 [0.48-1.09],0.1212002880685695
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",22715,58,0.80 [0.49-1.31],0.3754009819335526
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",22801,144,1.14 [0.78-1.67],0.4853552710579043
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",22761,104,0.91 [0.61-1.36],0.6373802033288102
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",22742,85,0.87 [0.57-1.32],0.5035313943273845
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",22700,43,0.85 [0.47-1.53],0.5935041939667216
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,22739,82,1.01 [0.63-1.63],0.9509697910974751
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Melanocytic naevi,27658,234,0.95 [0.73-1.24],0.6987539501563713
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Melanocytic naevi of trunk,27879,82,0.93 [0.59-1.45],0.7355601889610461
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Melanoma in situ,22692,90,0.76 [0.53-1.09],0.1346189496995589
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",22740,83,0.89 [0.57-1.39],0.6137199168792631
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",22813,156,0.81 [0.60-1.08],0.1531493172262023
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",22887,230,0.86 [0.65-1.12],0.2537194669859113
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",22754,97,0.66 [0.48-0.90],0.008338630430198
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Other benign neoplasms of skin,27696,169,0.90 [0.66-1.23],0.519610171717455
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",23612,955,1.00 [0.87-1.14],0.9747907941281282
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",23652,995,1.01 [0.88-1.15],0.9410994208999672
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,27613,383,0.95 [0.77-1.18],0.6420982035217653
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,25861,107,0.90 [0.60-1.35],0.6034337629458675
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,27302,72,0.85 [0.53-1.35],0.4844161362553009
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,26896,3045,0.84 [0.78-0.90],1.4043283281238886e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,26248,37,0.98 [0.47-2.03],0.946230322201411
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,27513,49,0.88 [0.49-1.57],0.6633454191618351
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,27329,1575,0.78 [0.71-0.86],2.218322299781643e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,27329,1575,0.78 [0.71-0.86],2.218322299781643e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,25826,72,0.81 [0.51-1.27],0.3529134441059637
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,27511,1300,0.84 [0.75-0.93],0.0013889393940008
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,27588,124,0.75 [0.54-1.04],0.0803594886716535
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,27283,53,0.60 [0.40-0.91],0.0150072889041968
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,27288,58,0.77 [0.47-1.24],0.2800080143737796
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,27707,243,0.80 [0.63-1.02],0.0768710109008085
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,27813,63,1.01 [0.59-1.74],0.9681807603527222
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",27670,206,0.79 [0.61-1.03],0.0802623568514221
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,26348,137,0.66 [0.50-0.87],0.0034203658990028
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,22468,261,0.63 [0.51-0.77],8.376039996983372e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,26470,71,0.91 [0.56-1.47],0.6883315187988519
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,26466,67,0.51 [0.37-0.71],6.544167165523787e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,22260,53,0.68 [0.42-1.10],0.113559426833274
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,25607,70,1.36 [0.76-2.41],0.3000379674401391
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,25240,251,0.74 [0.59-0.94],0.0117872145697016
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",27480,519,0.85 [0.71-1.01],0.0687337534841588
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,27256,295,1.41 [1.06-1.88],0.0185964826383117
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,27048,87,0.84 [0.55-1.29],0.4304171819876889
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,27521,1984,0.92 [0.84-1.01],0.0898696178163962
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,24700,1934,0.90 [0.82-0.99],0.0289600813343003
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",22267,60,0.52 [0.37-0.73],0.0001544523831695
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",24773,120,0.80 [0.56-1.13],0.2094507406308361
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,22498,291,0.68 [0.55-0.83],0.0002059540710366
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,22255,48,1.01 [0.54-1.89],0.9787723629782396
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,25414,3207,0.89 [0.82-0.96],0.0015890649097568
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,22414,207,0.64 [0.51-0.81],0.0001574567331418
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,22757,550,0.73 [0.63-0.86],0.0001146339034212
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,27822,379,0.78 [0.64-0.94],0.0089263443824825
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,27631,188,0.74 [0.57-0.97],0.0291802182357021
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,22309,102,0.78 [0.53-1.14],0.2004782673848994
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",22262,55,0.57 [0.39-0.83],0.0038976583885884
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,27021,2368,0.92 [0.84-1.00],0.0519397613165601
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,22423,216,0.68 [0.53-0.87],0.0025779992747612
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,22428,221,0.64 [0.51-0.81],0.0002081373855512
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",22749,542,0.79 [0.67-0.94],0.0068814739105742
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,22302,95,0.77 [0.51-1.16],0.2062025898952553
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,27621,178,0.77 [0.58-1.02],0.0656729394584655
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,22846,639,0.73 [0.63-0.84],1.781760420960175e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,22785,578,0.71 [0.61-0.83],6.88656664663477e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,25060,71,0.68 [0.45-1.01],0.0558466234331218
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,27005,4798,0.86 [0.81-0.91],1.985803004371462e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,24731,78,0.83 [0.54-1.29],0.4158270249989698
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,24742,89,0.74 [0.51-1.07],0.1064872758409577
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,27724,2120,0.81 [0.74-0.88],3.342887157780849e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",27729,2119,0.81 [0.74-0.89],5.052408572703082e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,24733,80,0.62 [0.44-0.88],0.0066520746352922
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,27510,1621,0.88 [0.79-0.97],0.0084760931016855
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",23767,1560,0.72 [0.66-0.79],2.875243268400212e-12
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,27913,189,0.80 [0.60-1.07],0.1400671315353994
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,27019,58,1.05 [0.58-1.90],0.8658591199439315
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,26023,134,0.87 [0.62-1.23],0.4328769110748719
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,26089,200,0.90 [0.67-1.20],0.4792926887166984
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",22480,273,0.68 [0.55-0.83],0.0001997301361632
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,26063,144,0.85 [0.60-1.19],0.3360427476681984
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1738,49,0.63 [0.35-1.11],0.1110676849355548
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1853,187,0.88 [0.65-1.20],0.4320177761552172
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,25944,25,0.98 [0.40-2.42],0.9653844003296967
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1720,32,0.67 [0.33-1.35],0.2628899340838242
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,27428,1509,0.89 [0.80-0.99],0.0334625315979175
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,27309,348,0.83 [0.67-1.03],0.094239193534813
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,25485,496,0.91 [0.76-1.10],0.3543796247454572
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,22956,749,0.84 [0.72-0.97],0.0214725155810872
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",27824,235,0.78 [0.61-1.00],0.0457487075134476
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),26896,57,0.56 [0.37-0.83],0.0041537184494421
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Angina pectoris,26361,902,0.87 [0.76-0.99],0.0409962820493336
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Aortic aneurysm,26941,102,0.62 [0.45-0.85],0.0032003359929712
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,26872,33,0.50 [0.31-0.78],0.0025395843256418
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",26993,154,0.73 [0.54-0.99],0.0439087235845063
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,18162,1520,0.79 [0.72-0.87],1.2179118121706957e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,AV-block,24440,248,0.70 [0.56-0.88],0.0020395831685048
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",27884,312,0.96 [0.76-1.23],0.7602068489826976
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Cardiac arrest,16774,132,0.63 [0.48-0.82],0.0007838971729617
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Cardiomyopathy,24331,139,0.88 [0.62-1.24],0.4553192415852788
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",24274,82,0.75 [0.50-1.12],0.1596480969985997
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,27923,34,0.64 [0.37-1.12],0.1162590908021768
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Conduction disorders,24939,747,0.78 [0.68-0.89],0.0003793588468022
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,26991,1544,0.86 [0.77-0.95],0.0030606760196287
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,25108,7403,0.90 [0.86-0.95],4.1121248561567184e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,DVT of lower extremities,26374,250,0.83 [0.65-1.06],0.1317760341354289
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Endocarditis,24255,63,0.62 [0.42-0.92],0.0172609760598667
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Heart failure, strict",27827,875,0.67 [0.60-0.75],1.2416942046019305e-11
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Hypertension,25743,6258,0.88 [0.84-0.93],2.136346860958513e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Hypertension, essential",25755,6270,0.88 [0.84-0.93],1.6454283354983272e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Hypertension, portal",27811,45,1.96 [0.90-4.27],0.0892529089336348
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",19652,167,0.77 [0.57-1.05],0.0954881197449596
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,19590,105,0.73 [0.51-1.06],0.1004478068722592
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Hypotension,27782,1135,0.82 [0.73-0.92],0.0005787482397925
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,27154,96,0.96 [0.62-1.48],0.8595576561810047
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",27193,1734,0.88 [0.80-0.97],0.0107762376580942
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",27606,467,0.89 [0.74-1.08],0.2339994697683716
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Left bundle-branch block,24496,304,0.72 [0.58-0.88],0.0012987054584763
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,27700,618,0.82 [0.70-0.96],0.0120960042509328
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",25955,496,0.77 [0.65-0.90],0.0016644963404439
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",27901,88,0.62 [0.45-0.86],0.0040004437200136
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",27921,246,0.90 [0.69-1.17],0.4260767280696763
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Oesophageal varices,26163,39,1.29 [0.60-2.78],0.508441945722878
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other aneurysm,26900,61,0.71 [0.46-1.09],0.1194135789894614
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other arrhythmias,24556,364,0.87 [0.70-1.07],0.1866333880015509
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,26905,66,0.53 [0.38-0.75],0.0003290982926049
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,27035,196,0.78 [0.59-1.02],0.0646752463584659
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,24352,160,0.71 [0.54-0.94],0.0178023775256042
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other disorders of veins,26221,97,0.76 [0.52-1.11],0.1503928239439973
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,26170,46,1.06 [0.55-2.03],0.8639836800470588
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,26649,39,0.74 [0.41-1.31],0.2957333122652676
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,26292,168,0.64 [0.50-0.82],0.0004376899788598
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,25023,831,0.76 [0.66-0.86],3.058377683222038e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,26691,44,1.15 [0.58-2.30],0.6862816027720409
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,27351,512,0.68 [0.58-0.78],1.5128640416694718e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,27342,325,0.71 [0.58-0.87],0.0009235411701981
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",27166,556,0.81 [0.69-0.95],0.0108991899292451
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16937,295,0.67 [0.56-0.80],1.4387566435432008e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Peripheral artery disease,27106,281,0.69 [0.56-0.85],0.0004876024791454
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),26456,332,0.87 [0.69-1.08],0.2055224084276674
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Pulmonary embolism,27468,451,0.87 [0.72-1.05],0.1420257361299715
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,27847,602,0.78 [0.67-0.91],0.001303832832708
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Right bundle-branch block,24421,229,0.75 [0.59-0.95],0.0165882132654254
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Secondary right heart disease,27334,317,0.70 [0.57-0.85],0.0005002869517447
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,26775,165,0.87 [0.63-1.20],0.3892844228356754
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",27599,541,0.91 [0.76-1.09],0.3142782013182562
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",27573,589,0.95 [0.79-1.13],0.5270817613513041
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,27119,71,1.78 [0.96-3.27],0.0659148505516461
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,26887,48,0.74 [0.44-1.24],0.2543078034481225
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Transient ischemic attack,27359,220,0.83 [0.64-1.07],0.1491274444073
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,27285,203,0.94 [0.70-1.28],0.7005961667002221
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Varicose veins,26593,469,0.92 [0.76-1.12],0.3982121662312117
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,26851,97,0.62 [0.45-0.86],0.0035812207395714
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Venous thromboembolism,27710,715,0.88 [0.76-1.03],0.1120373061783904
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",27880,225,0.67 [0.54-0.83],0.0002281267617342
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",24793,1889,0.88 [0.81-0.97],0.0096221310933719
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,Any mental disorder,27303,4399,0.89 [0.84-0.95],0.0002213848099498
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27848,268,0.72 [0.58-0.88],0.0018026650574656
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",24910,2006,0.91 [0.83-1.00],0.0399941865151771
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",22998,94,0.82 [0.54-1.23],0.3278171254322568
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,Smoking dependency,27506,1220,0.89 [0.79-1.01],0.0735887920003733
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",24314,1410,0.84 [0.75-0.93],0.0011465353161316
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,Vascular dementia,27412,103,0.70 [0.50-0.99],0.0447280968680026
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Alzheimer disease,27927,367,1.31 [1.02-1.69],0.0336095481932816
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",19048,60,2.44 [1.20-4.92],0.0131936966030059
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Bell's palsy,25725,87,0.61 [0.44-0.83],0.0021237655849097
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,26286,648,1.03 [0.87-1.23],0.7264860360957264
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Cerebral cysts,27511,222,0.87 [0.66-1.13],0.294300860357253
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,27853,284,0.80 [0.63-1.00],0.051787937299555
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,27432,40,2.10 [0.92-4.82],0.0798649176547663
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,27914,47,1.02 [0.54-1.92],0.9460003159122228
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",27344,55,0.79 [0.48-1.29],0.3435365145995972
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Epilepsy,26408,287,0.82 [0.66-1.03],0.0939725467149369
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,27503,1382,0.84 [0.76-0.94],0.0017487957306309
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,27877,523,0.83 [0.70-0.99],0.0341043890815087
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Falls/tendency to fall,27278,2958,0.91 [0.84-0.98],0.0116530707083113
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Generalized epilepsy,27551,47,0.63 [0.40-0.98],0.0386693078334298
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Hemiplegia,27797,228,0.78 [0.61-1.01],0.0602776612817328
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Hydrocephalus,27354,65,1.12 [0.63-1.96],0.7052966586067233
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,27907,77,1.02 [0.62-1.68],0.9243846743858516
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,25768,130,0.78 [0.57-1.07],0.1280704879337998
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,25706,68,1.15 [0.66-2.00],0.6209866588100175
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Memory loss,27284,98,0.98 [0.63-1.51],0.9125499443709244
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Migraine,26647,526,0.83 [0.70-0.98],0.0297033816298473
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",27811,472,0.78 [0.66-0.93],0.0049092788208901
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Motor neuron disease,19136,121,1.13 [0.75-1.70],0.5663649252344237
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,27705,144,0.86 [0.62-1.19],0.3595752826606715
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",27062,1424,0.93 [0.83-1.03],0.171617555722513
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Neurological diseases,26284,3886,0.94 [0.87-1.00],0.0511854629261026
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,27552,160,0.90 [0.65-1.25],0.5317575251904106
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",26070,432,0.96 [0.78-1.18],0.6987434968807101
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",27869,241,1.02 [0.77-1.36],0.8706289703029523
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,22482,676,1.08 [0.91-1.28],0.3726524693833717
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,27359,70,0.83 [0.52-1.33],0.4453678193501944
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Other disorders of nervous system,27414,125,1.02 [0.69-1.51],0.9166861594642288
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,27542,188,0.81 [0.61-1.07],0.1353100719439999
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Other facial nerve disorders,25735,97,0.62 [0.45-0.84],0.001948921665409
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Other headache syndromes,26198,77,0.86 [0.54-1.36],0.5142291732897162
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Other neurological diseases,27804,515,0.88 [0.74-1.05],0.1572901847806672
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Other sleep disorders,26536,415,0.82 [0.67-1.00],0.0477493045958313
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Parkinson's disease,27902,318,0.85 [0.68-1.06],0.1557498841839714
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,27374,85,0.84 [0.56-1.28],0.4230292654922639
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Restless leg syndrome,27926,103,1.31 [0.82-2.10],0.2554881749261738
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Sleep apnoea,27745,328,0.75 [0.61-0.93],0.0096021217156526
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Small fibre neuropathy,27668,40,0.95 [0.49-1.87],0.892468866206849
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,27917,151,1.00 [0.70-1.42],0.9983352553801184
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,25706,68,0.81 [0.51-1.29],0.3715866028783067
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,27927,371,1.31 [1.02-1.68],0.0353999103825454
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),27368,100,0.73 [0.51-1.05],0.0933371446702651
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,27333,113,0.91 [0.62-1.33],0.6134149194626095
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,27451,491,0.90 [0.74-1.08],0.2392451370873808
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,27779,176,0.89 [0.65-1.22],0.4680685385313375
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,26796,63,1.42 [0.77-2.63],0.2616059158470189
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,26785,52,0.72 [0.46-1.13],0.1573007478645631
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",27801,63,0.69 [0.45-1.04],0.0788204983842566
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,27633,168,1.15 [0.80-1.64],0.4449538989873317
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1726,37,0.85 [0.43-1.69],0.6415064632817264
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2077,71,0.91 [0.54-1.52],0.7137627527514439
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,27315,95,1.16 [0.73-1.86],0.5304783015629211
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,27743,1076,0.93 [0.82-1.06],0.2780795394623281
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",27498,765,0.92 [0.80-1.07],0.2973257762400855
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,27034,301,0.88 [0.70-1.10],0.2625669696194691
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",27831,871,0.94 [0.81-1.08],0.3642118017116368
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,27910,71,0.68 [0.46-1.01],0.0554789523506522
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,27752,792,0.93 [0.80-1.07],0.3010307546291511
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",27879,414,0.99 [0.80-1.22],0.8897382599499158
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,27830,211,1.02 [0.75-1.38],0.904217613150014
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,26775,42,0.81 [0.45-1.47],0.4945640768833657
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,26782,49,0.58 [0.39-0.86],0.006758945182487
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,26799,66,1.53 [0.83-2.81],0.1733098181006065
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,27835,737,0.97 [0.83-1.13],0.6868010192599754
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,27287,189,1.47 [1.03-2.10],0.036127469685871
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,27028,68,1.20 [0.68-2.10],0.5329840381690829
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,27570,105,1.15 [0.74-1.80],0.5348949886560957
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,27783,318,0.93 [0.74-1.17],0.5402596620350715
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,27177,217,0.87 [0.66-1.13],0.2989512221579941
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,27758,139,1.01 [0.70-1.46],0.9435660015800272
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,27581,483,0.89 [0.74-1.06],0.1950975038299523
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,27370,150,0.83 [0.60-1.13],0.231552001031192
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,26094,2552,0.94 [0.87-1.02],0.1435540471778716
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,27741,276,0.97 [0.75-1.26],0.8243276762175566
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,27901,158,0.87 [0.63-1.19],0.3830478480096743
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,27134,401,1.03 [0.83-1.28],0.8155013533003217
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,27530,65,1.50 [0.81-2.78],0.1930443217690871
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,27895,56,0.63 [0.42-0.96],0.0334165454191822
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,26823,90,0.86 [0.57-1.30],0.4637273524596619
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,26889,156,1.07 [0.75-1.53],0.7021626929840828
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,26777,110,1.17 [0.75-1.81],0.4889340237020444
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,27033,73,1.11 [0.66-1.88],0.6862840222224386
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",26727,60,1.27 [0.69-2.33],0.4420769495757111
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,27220,122,0.93 [0.64-1.35],0.6884290189879931
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",27281,183,0.94 [0.69-1.29],0.7150484327666379
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,26869,136,1.11 [0.75-1.63],0.6092817940472531
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,26768,101,0.87 [0.59-1.29],0.4959044239399767
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,26744,77,0.97 [0.60-1.58],0.901742131935538
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,25679,2137,0.97 [0.88-1.06],0.4627395804098821
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,26819,86,0.78 [0.53-1.15],0.2024981685785334
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,27657,437,0.90 [0.74-1.09],0.2711537800800118
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,27269,49,0.77 [0.45-1.32],0.3388787778829445
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),27391,171,0.89 [0.65-1.21],0.4568533857571552
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,27679,118,0.88 [0.61-1.28],0.4985338407068718
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,27880,120,1.06 [0.71-1.59],0.7679389329199369
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,27799,145,0.92 [0.66-1.29],0.6306013333471049
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,27631,70,0.62 [0.44-0.88],0.007788007165524
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,27634,73,1.38 [0.78-2.43],0.2654493695517247
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,27824,826,0.86 [0.75-0.99],0.0356384965341836
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,27564,566,0.82 [0.70-0.97],0.0179145953246118
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,27122,124,1.14 [0.75-1.71],0.544004815700813
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,27086,88,0.86 [0.57-1.32],0.4993498862035572
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Acute pharyngitis,27648,87,0.79 [0.53-1.18],0.2529710328576441
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,27799,238,0.87 [0.67-1.12],0.2841978064562304
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,27627,66,0.75 [0.49-1.16],0.1946735243759783
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,All influenza,26170,129,0.77 [0.55-1.07],0.1162674386583155
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),26168,127,0.76 [0.55-1.07],0.1122089625877736
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Allergic asthma (mode),19852,130,0.89 [0.63-1.27],0.5294440246836569
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Allergic rhinitis,27768,293,1.00 [0.78-1.28],0.9946361206026596
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",21629,2100,0.92 [0.84-1.01],0.0767433625640666
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",21795,2073,0.92 [0.84-1.01],0.0920191686150138
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),27502,127,0.83 [0.58-1.18],0.3032055382855881
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",26110,69,0.94 [0.56-1.57],0.8029218509654438
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Bronchiectasis,24157,416,0.77 [0.64-0.92],0.0037983241742059
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",23812,71,0.80 [0.51-1.26],0.3310055048159919
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,26758,3017,0.90 [0.84-0.97],0.0064346390440647
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",26618,62,0.74 [0.48-1.15],0.1824399324063341
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Chronic sinusitis,26704,148,1.41 [0.95-2.09],0.0924666393449926
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",27750,1080,0.81 [0.72-0.92],0.000733516942232
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Deviated nasal septum,26629,73,0.91 [0.57-1.46],0.6970905034899331
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,25800,5243,0.88 [0.84-0.94],1.9529174167344926e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",26892,336,0.86 [0.69-1.06],0.1606102694636479
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Early onset COPD,26993,323,0.75 [0.61-0.92],0.0062238412613392
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Emphysema,24021,280,0.76 [0.58-0.98],0.0315523574837365
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,26266,236,0.68 [0.55-0.84],0.0004831607107577
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Influenza and pneumonia,27730,1689,0.76 [0.69-0.83],3.15902242968063e-09
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Interstitial lung disease,26307,277,0.68 [0.56-0.84],0.0002452785860144
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Later onset COPD,26992,757,0.85 [0.73-0.99],0.0395758316816183
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,27920,234,0.83 [0.64-1.07],0.1416982776853153
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Nasal polyp,26625,69,0.88 [0.54-1.41],0.5874946049840837
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,27694,937,0.84 [0.74-0.95],0.0067102002147625
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Other diseases of pleura,27733,1780,0.76 [0.69-0.83],8.74682519086397e-10
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,27356,800,0.95 [0.82-1.10],0.5261532951713912
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Other pleural conditions,25989,36,0.91 [0.46-1.80],0.7937220313056881
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,27845,353,0.68 [0.57-0.81],2.442147756589148e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,27836,1198,0.75 [0.67-0.83],8.11135625118118e-08
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Pleural effusion,26819,866,0.76 [0.67-0.86],1.600599528432895e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Pleural plaque,26000,47,1.36 [0.66-2.79],0.3988868683689153
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",27494,1453,0.74 [0.67-0.82],1.393320206041579e-09
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,27890,204,0.76 [0.59-0.98],0.0356680456006792
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Pneumothorax,26046,93,0.67 [0.47-0.94],0.0216259119772795
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Pollen allergy,27894,245,1.02 [0.77-1.34],0.8850354431543229
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Pulmonary oedema,27557,65,0.57 [0.39-0.83],0.003472508079913
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Respiratory insufficiency,19775,53,0.70 [0.43-1.14],0.14927448623557
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,27669,912,0.84 [0.74-0.96],0.0093341881280547
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,26849,293,1.00 [0.78-1.28],0.974793001172787
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Viral pneumonia,26258,217,0.83 [0.64-1.09],0.1907083539672031
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",27512,170,0.94 [0.68-1.30],0.7046048342197967
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13490,110,0.80 [0.56-1.15],0.2264580372422084
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,19889,38,0.64 [0.38-1.07],0.0857681149849291
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Acute appendicitis,27738,144,1.02 [0.72-1.46],0.8985745640357461
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Acute gastritis,20942,91,1.20 [0.74-1.94],0.4608458365763879
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Acute pancreatitis,25578,165,0.80 [0.59-1.09],0.1572142075330239
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Acute peritonitis,27334,90,1.01 [0.64-1.59],0.977837654638874
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Alcoholic liver disease,27031,35,0.53 [0.34-0.83],0.0061159489445952
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Barrett oesophagus,21196,345,0.98 [0.78-1.23],0.8709776224026197
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",25493,80,0.94 [0.58-1.51],0.7898434686380086
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",27486,80,0.94 [0.58-1.52],0.8133524777734616
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Cholecystitis,25605,192,0.77 [0.59-1.02],0.0666121837621711
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Cholelithiasis,26623,1210,0.89 [0.79-1.00],0.0601341342424708
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Chronic gastritis,21196,345,1.06 [0.83-1.34],0.6537527450120784
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Chronic pancreatitis,25456,43,0.75 [0.44-1.28],0.2837240835560597
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",27841,75,1.55 [0.87-2.77],0.1372764112600706
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Coeliac disease,26339,155,1.00 [0.71-1.40],0.9934023357350128
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Collagenous colitis,25984,115,1.11 [0.73-1.70],0.621251463876503
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,27785,153,1.01 [0.71-1.42],0.9738579412406776
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Constipation,27575,1760,0.94 [0.85-1.03],0.1864708541452325
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Crohn disease,25966,97,0.85 [0.57-1.27],0.4299978732130302
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",27559,73,0.78 [0.51-1.21],0.2683231869347564
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Crohn's disease NAS,25970,101,0.88 [0.59-1.31],0.5229996446992267
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Dental caries,27079,236,0.80 [0.63-1.02],0.0733466987541106
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,26275,2515,0.96 [0.88-1.04],0.3321921579863472
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Diseases of appendix,27781,187,0.98 [0.72-1.32],0.8760055558610561
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Diseases of liver,27826,830,0.87 [0.75-1.00],0.0464106267402237
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",25587,4736,0.97 [0.91-1.03],0.268145713149348
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27446,603,0.87 [0.74-1.02],0.0958339579971014
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Diseases of peritoneum,27802,558,0.91 [0.77-1.09],0.3103262895448171
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,26964,121,0.81 [0.57-1.14],0.2184429752992759
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Diseases of salivary glands,26807,66,0.83 [0.52-1.33],0.4447823546624546
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Diseases of the digestive system,27622,1438,0.87 [0.78-0.96],0.0073773718636901
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Diseases of tongue,26819,114,0.98 [0.66-1.46],0.9339488379786368
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",27041,1628,0.85 [0.77-0.94],0.0017782455093396
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,23126,3275,0.90 [0.84-0.96],0.002849064022288
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Duodenal ulcer,20984,133,0.83 [0.59-1.16],0.2653290722525072
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",27876,112,0.85 [0.58-1.25],0.4120390858459599
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,27821,63,0.80 [0.51-1.25],0.3262346560263313
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,27093,97,1.21 [0.75-1.96],0.4305171584533007
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,19966,115,1.12 [0.73-1.70],0.6065273634817051
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Functional dyspepsia,21521,670,0.98 [0.83-1.15],0.7724701184693371
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Gastric ulcer,21204,353,0.78 [0.64-0.95],0.0133044396546811
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,23709,2858,0.93 [0.86-1.01],0.086663483613005
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,21330,479,0.81 [0.68-0.96],0.0170343962431439
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,21841,8645,0.97 [0.93-1.02],0.1976117870593636
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,GI-bleeding,27345,1161,0.82 [0.73-0.92],0.0006076641419007
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,26907,64,0.81 [0.50-1.32],0.4018771319174891
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,20841,1285,0.94 [0.84-1.05],0.2882285487207857
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",27037,41,1.05 [0.52-2.13],0.8822156226623896
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Hernia,26719,2959,0.93 [0.86-1.01],0.0718915705945298
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Impacted teeth,27832,58,0.80 [0.50-1.27],0.3444756975968892
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Impaction of intestines,19916,65,0.65 [0.44-0.95],0.0268171850237629
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Inguinal hernia,23933,173,0.84 [0.63-1.12],0.233801353324606
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,19956,105,0.99 [0.65-1.50],0.9590860565976704
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Intestinal malabsorption,26366,182,0.98 [0.72-1.33],0.8870566883188082
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,20689,838,0.93 [0.81-1.07],0.322873579252986
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,27911,366,0.83 [0.67-1.02],0.0773753376839738
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,26710,841,0.89 [0.77-1.02],0.0945211852500586
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,27002,1133,0.89 [0.79-1.00],0.0473632926619427
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Oesophageal obstruction,21014,163,0.70 [0.54-0.90],0.0062768973764523
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Oesophagitis,21431,580,0.89 [0.76-1.06],0.1935665763636642
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,27880,162,1.02 [0.73-1.42],0.9247562146277926
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,23821,61,0.75 [0.46-1.21],0.2332395879448079
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,21146,1295,0.96 [0.85-1.07],0.4412910406239555
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,25720,307,0.79 [0.63-0.99],0.0366215547497398
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,25604,191,0.87 [0.65-1.16],0.3418445666587771
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of intestine,21476,1625,0.89 [0.80-0.98],0.0186003274495221
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of intestines,25702,5851,0.94 [0.89-0.99],0.0186238588883514
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,26811,239,0.93 [0.72-1.22],0.6055247738605385
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of liver,27693,697,0.91 [0.78-1.07],0.2556460165061229
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,21445,594,0.85 [0.73-1.00],0.052374296879184
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of pancreas,25576,163,0.76 [0.56-1.01],0.0618097851910114
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,27736,492,0.90 [0.75-1.08],0.2713028907615836
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,21954,1103,0.93 [0.82-1.05],0.2427792678310719
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,27364,1180,0.82 [0.74-0.92],0.0007238791858758
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,27042,199,1.00 [0.74-1.35],0.9840171846075976
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,21669,1818,0.91 [0.83-1.00],0.0567075383253602
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),23012,2161,0.98 [0.89-1.07],0.6681261578763126
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,27100,104,1.29 [0.81-2.06],0.2880384772440321
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,26864,995,0.92 [0.81-1.05],0.2213655271537861
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",20188,337,0.93 [0.74-1.16],0.5058261555991672
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,27810,73,0.78 [0.52-1.16],0.2188624479612685
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,20356,505,0.94 [0.78-1.14],0.5369478107437902
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",26318,134,1.14 [0.77-1.69],0.5091557688743003
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Recurring oral aphthae,27919,69,1.01 [0.61-1.70],0.9562050123057856
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,26845,129,1.04 [0.71-1.52],0.8488987065715493
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Toxic colitis,25937,68,1.01 [0.59-1.73],0.9629714133990536
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,21088,237,1.14 [0.85-1.54],0.3746966126320706
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Ulcerative colitis,26042,173,0.76 [0.58-1.00],0.0465704236530324
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",26010,141,0.79 [0.58-1.08],0.1363924448499749
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Umbilical hernia,23932,172,0.79 [0.59-1.06],0.1194257893700292
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,20045,194,0.68 [0.53-0.86],0.0014480124177894
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Ventral hernia,24023,263,0.80 [0.63-1.01],0.0608101053370348
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Volvulus,19939,88,0.69 [0.49-0.98],0.0358347849783785
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,27837,264,1.08 [0.82-1.41],0.5888911984744565
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,27601,77,0.76 [0.51-1.14],0.1794615398515653
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,25825,224,0.90 [0.68-1.17],0.4180553789340941
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,27383,648,0.77 [0.67-0.90],0.0006327306735577
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",26884,149,0.80 [0.59-1.09],0.156135260916241
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,25948,347,0.68 [0.56-0.81],2.839450321847825e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,27607,286,1.07 [0.82-1.39],0.6115372135342727
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,27815,494,0.93 [0.77-1.12],0.4413862668383669
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,27373,52,0.74 [0.45-1.23],0.2520758661560866
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,26295,3231,0.85 [0.79-0.91],3.499798984949332e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,27468,488,0.88 [0.74-1.05],0.166593094556407
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,27315,335,0.92 [0.74-1.16],0.4935836349613921
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,27601,866,0.79 [0.69-0.90],0.0003038442446989
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",27902,79,0.73 [0.50-1.07],0.1099504284247744
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,25692,91,0.72 [0.50-1.04],0.0785919146422684
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,27027,47,0.88 [0.49-1.58],0.6655109349948851
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,27592,271,1.12 [0.85-1.47],0.4295004715012172
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,26024,423,0.94 [0.77-1.15],0.5422272724451722
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,25650,49,1.10 [0.58-2.08],0.7737699570811236
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,27819,84,0.78 [0.52-1.18],0.2451753305575932
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,26894,159,0.79 [0.59-1.07],0.1334068800924614
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,27693,169,0.73 [0.56-0.96],0.0267623945193677
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,27379,58,0.75 [0.45-1.25],0.2674676988843643
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,25668,67,1.32 [0.74-2.35],0.3523444608163799
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,27227,1626,0.85 [0.77-0.94],0.0013160760108581
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",26059,458,0.97 [0.80-1.19],0.7849435995306315
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,25655,54,1.05 [0.58-1.92],0.8653357739078799
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,27839,315,0.73 [0.60-0.89],0.0014561924071912
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,27407,86,1.11 [0.68-1.80],0.6794412285230285
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,27764,240,0.73 [0.58-0.91],0.0058984381869411
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,27874,301,1.03 [0.80-1.32],0.8234326047806211
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,25763,162,0.98 [0.70-1.36],0.8869935778260337
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,25869,268,0.96 [0.74-1.23],0.7252760820834429
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,27859,286,1.02 [0.79-1.32],0.8528939933878826
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",25806,205,0.64 [0.51-0.81],0.0001994210974604
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,27890,155,0.83 [0.60-1.13],0.2281130999961209
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,23830,127,0.59 [0.46-0.75],1.6515676044396686e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,25358,6510,0.92 [0.87-0.97],0.001151461752311
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,23933,5085,0.91 [0.86-0.96],0.0014490829199829
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,23783,80,0.81 [0.53-1.25],0.3510724137844883
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,23950,155,1.36 [0.92-1.99],0.1212183405530039
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,24010,215,1.04 [0.77-1.40],0.7839385090564637
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,27629,116,0.85 [0.59-1.22],0.3732871105928375
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",23915,120,0.68 [0.50-0.92],0.0112202687302674
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,20249,1401,0.91 [0.82-1.02],0.1145216582067893
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",27772,222,0.86 [0.66-1.12],0.2618462852346907
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,24419,624,0.98 [0.82-1.16],0.7829762232851909
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,23470,8277,0.91 [0.87-0.96],0.0001026322857524
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,25017,144,0.70 [0.53-0.92],0.0118208947358256
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,23841,138,0.84 [0.60-1.18],0.3136186821005239
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,24402,699,1.02 [0.87-1.20],0.8223108721552242
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,26892,3097,0.91 [0.85-0.98],0.0136825757641719
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,23882,179,1.00 [0.73-1.38],0.9871654030154708
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,24092,389,0.79 [0.65-0.95],0.0144919604084242
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,23877,174,1.08 [0.77-1.51],0.6601247251748537
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,26953,107,1.44 [0.90-2.33],0.1301626677790407
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,20760,1912,0.85 [0.78-0.93],0.0006187495812401
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,19079,231,0.67 [0.52-0.85],0.0013250092128406
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",27914,228,0.70 [0.55-0.89],0.0032098889816712
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18950,102,0.82 [0.57-1.20],0.3081900367337883
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),19426,578,0.85 [0.72-1.00],0.0511718455028741
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,24036,333,0.91 [0.73-1.14],0.4081696375270039
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,19495,647,1.06 [0.89-1.26],0.5280282088830534
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,23864,69,1.00 [0.59-1.68],0.9930882941964604
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,24524,729,0.84 [0.73-0.97],0.0213553487435783
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,24134,339,0.92 [0.73-1.15],0.4481144914493044
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,19451,603,1.04 [0.87-1.25],0.6465297268908565
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,23798,95,1.19 [0.74-1.90],0.4767402373382224
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",23773,70,0.91 [0.56-1.48],0.7000696880036883
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,24922,49,0.99 [0.54-1.84],0.98256423290108
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,27434,2561,0.83 [0.77-0.90],1.6272664993341716e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,26715,1842,0.81 [0.75-0.89],3.362423886413199e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",27725,615,0.79 [0.68-0.92],0.0029566473585701
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,21959,3111,0.84 [0.78-0.90],1.4728683550956633e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,18923,75,0.89 [0.56-1.42],0.6320355107297202
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,23808,105,0.94 [0.62-1.42],0.7712560477110729
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,18892,44,0.92 [0.48-1.75],0.7885661932058844
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),19055,207,0.90 [0.68-1.20],0.4883726425970449
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,25170,297,0.87 [0.69-1.10],0.2486352822637519
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,25473,600,0.87 [0.74-1.02],0.0965439552825832
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,27896,114,0.83 [0.58-1.20],0.3285063727135334
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",25882,2087,0.92 [0.84-1.01],0.084181460303101
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,23836,133,0.83 [0.60-1.15],0.2695868355003219
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),19081,233,0.77 [0.60-0.97],0.02958794785488
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,24627,832,0.91 [0.79-1.05],0.1843997850876778
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,21441,2593,0.90 [0.83-0.97],0.0087490548359642
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,26979,133,1.23 [0.82-1.85],0.3187605924565594
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,27909,76,0.79 [0.52-1.20],0.2734981320016252
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,23786,83,1.42 [0.83-2.42],0.2010202682852843
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",25220,1517,0.88 [0.79-0.97],0.0141913746471196
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,23788,85,0.81 [0.54-1.23],0.3228481580282941
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,20882,2034,0.91 [0.83-1.00],0.0395328071475422
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,25011,138,0.88 [0.63-1.24],0.4612038546513305
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,23766,63,0.79 [0.50-1.24],0.3022050345302081
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,24002,207,0.85 [0.64-1.11],0.2339816212417617
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,24310,607,0.86 [0.73-1.01],0.0634927202169611
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,27361,515,0.79 [0.67-0.93],0.0049109734734357
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,24456,661,1.00 [0.84-1.18],0.9999176560010432
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,27740,595,0.81 [0.69-0.95],0.0094043473906234
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,27898,70,0.61 [0.43-0.86],0.0054805166803218
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,23929,226,0.89 [0.68-1.17],0.397845782472818
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,21425,943,0.92 [0.81-1.06],0.2391454250922499
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,24383,680,0.88 [0.76-1.03],0.1204777688598885
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],23827,124,0.89 [0.62-1.26],0.4997326368676446
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",18925,77,0.66 [0.45-0.97],0.0333236748500192
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,21549,2701,0.87 [0.80-0.94],0.0003403393153714
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,19713,865,0.86 [0.75-0.98],0.0276867502775664
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,27146,300,1.00 [0.78-1.27],0.9694878585381996
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",27868,86,0.80 [0.53-1.21],0.2993286228775243
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",25582,57,0.71 [0.43-1.17],0.1798705974034285
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,18925,77,0.75 [0.50-1.12],0.1600323691167843
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,23909,114,0.82 [0.57-1.18],0.2788836509807664
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,19466,618,0.76 [0.66-0.89],0.0004748730987413
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,24045,342,0.87 [0.70-1.09],0.2284750733908629
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,24087,292,1.18 [0.90-1.55],0.2215034016029373
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,24081,286,0.98 [0.76-1.26],0.863094319950992
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,21560,86,0.60 [0.44-0.82],0.0012511459513881
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",27904,76,0.62 [0.44-0.87],0.0054837295919647
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,24353,650,0.79 [0.69-0.92],0.0019195869262224
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],27012,166,0.61 [0.49-0.77],1.803435591960509e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,26584,2881,0.91 [0.84-0.98],0.0168239063139693
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",23859,156,0.78 [0.58-1.05],0.1010505419279967
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,24382,587,0.95 [0.80-1.13],0.572304463743037
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,26172,273,0.81 [0.64-1.03],0.0819439184301345
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,24082,287,1.07 [0.82-1.39],0.6083004370189959
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,25597,1802,0.88 [0.80-0.97],0.0115712845006024
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,25016,1221,0.92 [0.82-1.04],0.1893721277895846
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],23770,67,0.69 [0.45-1.05],0.0850358694768688
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,27076,230,0.64 [0.53-0.79],2.04996649154504e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,23912,209,1.35 [0.97-1.87],0.0772486459860431
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,23831,128,0.92 [0.64-1.33],0.6551549667319462
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),18902,54,0.94 [0.53-1.67],0.828356288614056
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Acute renal failure,26825,1289,0.80 [0.72-0.89],5.0209467863065896e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20909,104,0.89 [0.61-1.30],0.5354204419841146
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,27207,111,0.69 [0.51-0.95],0.0211747200558925
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,27762,240,0.99 [0.75-1.30],0.935526267478866
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,27550,28,0.79 [0.39-1.59],0.5065981814447409
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,27061,1525,0.93 [0.84-1.04],0.2213845737742223
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,27748,82,0.89 [0.56-1.41],0.6103146204110426
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,27712,250,1.11 [0.83-1.49],0.4709352333309251
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Cystitis,24631,259,0.80 [0.63-1.01],0.0587187500533475
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Dialysis,25591,55,0.74 [0.45-1.21],0.2340439328289823
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Disorders of breast,27440,344,0.95 [0.76-1.19],0.6405405055451825
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Endometriosis,20989,184,1.13 [0.82-1.57],0.4522120146926939
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",21210,405,1.01 [0.82-1.24],0.9266972522852898
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21833,1028,0.83 [0.74-0.93],0.0017473316010347
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,21738,5171,0.92 [0.87-0.97],0.0040863236522586
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,27731,65,0.67 [0.44-1.02],0.0608020486019503
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,25414,216,0.73 [0.57-0.92],0.0079036709666806
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,27369,405,0.97 [0.79-1.20],0.8084278869250989
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Irregular menses,27450,130,1.06 [0.73-1.54],0.761791587046801
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Menorrhagia,21118,313,1.05 [0.83-1.33],0.6804032536516436
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,24449,77,0.70 [0.48-1.03],0.0701698250413933
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,23306,2501,0.91 [0.84-0.99],0.0220809046809415
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,20948,143,0.91 [0.65-1.27],0.5615934967461624
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",27913,68,0.81 [0.51-1.28],0.3648329621051582
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",27916,76,0.82 [0.52-1.29],0.3983876008682591
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,26656,2284,0.88 [0.81-0.96],0.0028660046402553
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,24858,486,0.90 [0.74-1.08],0.2464848455854218
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,27218,122,1.33 [0.87-2.04],0.1936557201198568
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,27862,400,0.90 [0.73-1.10],0.3066939318053377
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,27865,93,0.75 [0.52-1.07],0.1118779435398797
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,26328,1956,0.85 [0.78-0.93],0.0002728221185109
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,27173,209,1.23 [0.89-1.70],0.2061625032554508
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20964,159,0.95 [0.69-1.32],0.7557816900953507
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",21179,374,1.01 [0.81-1.26],0.9383086677855248
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20919,114,0.93 [0.64-1.37],0.7264672089656574
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,21016,211,0.79 [0.62-1.02],0.0720771502827524
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,25466,268,0.72 [0.58-0.89],0.002002804132515
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,27591,129,0.74 [0.54-1.02],0.0702217814207104
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,21119,314,1.13 [0.88-1.45],0.3458029728931412
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,20913,108,0.75 [0.54-1.03],0.0755092685880044
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21462,657,0.92 [0.78-1.07],0.2799228432731979
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,20968,163,0.82 [0.61-1.10],0.1928073014012762
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21411,606,1.02 [0.86-1.22],0.7860910565490496
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,27705,39,0.99 [0.50-1.96],0.9724930207806955
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,27726,2528,0.88 [0.81-0.96],0.0026083733676765
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",25364,166,0.84 [0.62-1.14],0.2641776209114758
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,25641,105,0.88 [0.59-1.32],0.5316282708850033
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,27558,36,0.75 [0.41-1.36],0.3444601284837464
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Urethral stricture,24520,148,0.96 [0.68-1.35],0.8061629665305958
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27797,275,0.93 [0.73-1.20],0.5930866274042887
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Uterine polyps,20948,143,0.78 [0.58-1.06],0.1087049550737153
